Tandem Diabetes Care Inc (TNDM)
47.30
+0.38
(+0.80%)
USD |
NASDAQ |
May 17, 16:00
47.30
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Revenue (Annual): 747.72M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 747.72M |
| December 31, 2022 | 801.22M |
| December 31, 2021 | 702.80M |
| December 31, 2020 | 498.83M |
| December 31, 2019 | 362.30M |
| December 31, 2018 | 183.87M |
| Date | Value |
|---|---|
| December 31, 2017 | 107.60M |
| December 31, 2016 | 84.25M |
| December 31, 2015 | 72.85M |
| December 31, 2014 | 49.72M |
| December 31, 2013 | 29.01M |
| December 31, 2012 | 2.475M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
362.30M
Minimum
2019
801.22M
Maximum
2022
622.57M
Average
702.80M
Median
2021
Revenue (Annual) Benchmarks
| Insulet Corp | 1.697B |
| Abbott Laboratories | 40.11B |
| Stryker Corp | 20.50B |
| Twist Bioscience Corp | 245.11M |
| Perspective Therapeutics Inc | -- |